Company Filing History:
2 out of 15,488 
1 out of 1 
1 out of 896 
Years Active: 2015-2019
Title: Innovations of Olulanu H Aina in Bladder Cancer Research
Introduction
Olulanu H Aina, an accomplished inventor based in Elk Grove, California, has made significant contributions to the field of bladder cancer research. With a total of three patents to his name, Aina's work focuses on innovative approaches to diagnostics and targeted therapy for bladder cancer, showcasing his commitment to improving patient outcomes.
Latest Patents
Among Aina's latest patents are the bladder cancer specific ligand peptides, which encompass the amino acid sequence XDGRXGF (SEQ ID NO: 1). This invention offers various applications, such as imaging detection for diagnosing bladder cancer, localization of tumors to enhance transurethral resection procedures, and follow-up imaging to replace or complement costly cystoscopy methods. Furthermore, these peptides are pivotal in developing targeted therapies for both superficial and metastatic bladder cancer, illustrating Aina's dedication to advancing cancer treatment.
Career Highlights
Aina has built a robust career in the academic and research landscape, particularly with the University of California and The Regents of the University of California. His work in these institutions has facilitated groundbreaking research and innovation in the biomedical field, underlining his role as a key figure in cancer research.
Collaborations
Throughout his career, Aina has collaborated with esteemed colleagues such as Chong-Xian Pan and Hongyong Zhang. These partnerships highlight the importance of teamwork in pushing the boundaries of scientific inquiry and developing novel solutions for pressing medical challenges.
Conclusion
Olulanu H Aina's contributions to bladder cancer research exemplify the essence of innovation in healthcare. His patents not only reflect his expertise as an inventor but also his dedication to improving the lives of patients facing bladder cancer. As the field continues to evolve, Aina's work will undoubtedly impact the future of cancer diagnostics and treatment strategies.